0
Treatment of Schizoaffective Disorder and Schizophrenia With Mood Symptoms
Douglas F. Levinson, M.D.; C. Umapathy, M.D.; Mohamado Musthaq, M.D.
Prediction of Antidepressant Effects of Sleep Deprivation by Metabolic Rates in the Ventral Anterior Cingulate and Medial Prefrontal Cortex
Joseph Wu, M.D.; Monte S. Buchsbaum, M.D.; J. Christian Gillin, M.D.; Cheuk Tang, M.S.; Stephanie Cadwell, B.A.; Michael Wiegand, M.D.; Ahmad Najafi, Ph.D.; Eric Klein, B.S.; Kaye Hazen, B.S.; William E. Bunney, Jr., M.D.
Bipolar Disorder: Anomalous Brain Asymmetry Associated With Psychosis
Martin Reite, M.D.; Peter Teale, M.S.E.E.; Donald C. Rojas, Ph.D.; David Arciniegas, M.D.; Jeanelle Sheeder, B.A.
Clinical Outcome in a Randomized 1-Year Trial of Clozapine Versus Treatment as Usual for Patients With Treatment-Resistant Illness and a History of Mania
Trisha Suppes, M.D., Ph.D.; Andrew Webb, B.A.; Betty Paul, L.V.N.; Thomas Carmody, Ph.D.; Helena Kraemer, Ph.D.; A. John Rush, M.D.
Changes in Weight During a 1-Year Trial of Fluoxetine
David Michelson, M.D.; Jay D. Amsterdam, M.D.; Fredrick M. Quitkin, M.D.; Fredrick W. Reimherr, M.D.; Jerrold F. Rosenbaum, M.D.; John Zajecka, M.D.; Karen L. Sundell, B.S.; Yongman Kim, Ph.D.; Charles M. Beasley, Jr.
Three-Year Outcomes of Maintenance Nortriptyline Treatment in Late-Life Depression: A Study of Two Fixed Plasma Levels
Charles F. Reynolds, III, M.D.; James M. Perel, Ph.D.; Ellen Frank, Ph.D.; Cleon Cornes, M.D.; Mark D. Miller, M.D.; Patricia R. Houck, M.S.H.; Sati Mazumdar, Ph.D.; Jacqueline A. Stack, M.S.N.; Bruce G. Pollock, M.D., Ph.D.; Mary Amanda Dew, Ph.D.; David J. Kupfer, M.D.
Prognosis of Depression in Elderly Community and Primary Care Populations: A Systematic Review and Meta-Analysis
Martin G. Cole, M.D., F.R.C.P.(C.); Fran殩s Bellavance, Ph.D.; Asmaຯ Mansour, M.S.E.
Three-Dimensional Analysis With MRI and PET of the Size, Shape, and Function of the Thalamus in the Schizophrenia Spectrum
Erin A. Hazlett, Ph.D.; Monte S. Buchsbaum, M.D.; William Byne, M.D., Ph.D.; Tse-Chung Wei, Ph.D.; Jacqueline Spiegel-Cohen, M.S.; Craig Geneve, B.S.; Rayzel Kinderlehrer, B.S.; M. Mehmet Haznedar, M.D.; Lina Shihabuddin, M.D.; Larry J. Siever, M.D.
Change in Basal Ganglia Volume Over 2 Years in Patients With Schizophrenia: Typical Versus Atypical Neuroleptics
Patricia Westmoreland Corson, M.D.; Peg Nopoulos, M.D.; Del D. Miller, Pharm.D., M.D.; Stephan Arndt, Ph.D.; Nancy C. Andreasen, M.D., Ph.D.
Changes in Levels of Phosphorus Metabolites in Temporal Lobes of Drug-Naive Schizophrenic Patients
Hiroshi Fukuzako, M.D.; Tsuyoshi Fukuzako, M.D.; Tomo Hashiguchi, M.D.; Satoshi Kodama, M.D.; Morikuni Takigawa, M.D.; Toshiro Fujimoto, M.D.
High Midbrain [18F]DOPA Accumulation in Children With Attention Deficit Hyperactivity Disorder
Monique Ernst, M.D., Ph.D.; Alan J. Zametkin, M.D.; John A. Matochik, Ph.D.; Daisy Pascualvaca, Ph.D.; Peter H. Jons, M.A.; Robert M. Cohen, Ph.D., M.D.
Effect of Alcohol on Social Phobic Anxiety
Joseph A. Himle, Ph.D.; James L. Abelson, M.D., Ph.D.; Hedieh Haghightgou, M.S.W.; Elizabeth M. Hill, Ph.D.; Randolph M. Nesse, M.D.; George C. Curtis, M.D.
Study of Stalkers
Paul E. Mullen, M.B.B.S., D.Sc., F.R.C.Psych.; Michele Path纯, M.B.B.S., F.R.A.N.Z.C.P.; Rosemary Purcell, B.A., M.Psych.; Geoffrey W. Stuart, B.A., B.Sc.(Hons.), Ph.D.
Occurrence and Management of Depression in the Context of Naltrexone Treatment of Alcoholism
Conor K. Farren, M.B., Ph.D., F.R.C.P.I., M.R.C.Psych.; Stephanie S. O’Malley, Ph.D.
Differential Effect of Number of Previous Episodes of Affective Disorder on Response to Lithium or Divalproex in Acute Mania
Alan C. Swann, M.D.; Charles L. Bowden, M.D.; Joseph R. Calabrese, M.D.; Steven C. Dilsaver, M.D.; David D. Morris, Ph.D.
Evaluation of Bipolar Disorder in Inpatients With Prelingual Deafness
Nathan A. Shapira, M.D., Ph.D.; Melissa P. DelBello, M.D.; Toby D. Goldsmith, M.D.; Betty M. Rosenberger, I.C./T.C.; Paul E. Keck, Jr., M.D.
Clozapine-Associated Elevation in Serum Triglycerides
Bruce D. Gaulin, M.S., Pharm.; John S. Markowitz, Pharm.D.; Charles F. Caley, Pharm.D.; Lori A. Nesbitt, Pharm.D.; Robert L. Dufresne, Ph.D.
Systematic Mutation Analysis of the Catechol O-Methyltransferase Gene as a Candidate Gene for Schizophrenia
Chia-Hsiang Chen, M.D., Ph.D.; Yu-Ru Lee, M.Sc.; Ming-Yi Chung, Ph.D.; Fu-Chuan Wei, M.D.; Farn-Jong Koong, M.D.; Cheng-Kuang Shaw, D.D.S., Ph.D.; Jih-I Yeh, M.D., Ph.D.; Kwang-Jen Hsiao, Ph.D.
Suicidal Behavior in Schizophrenia: Characteristics of Individuals Who Had and Had Not Attempted Suicide
Jill M. Harkavy-Friedman, Ph.D.; Kathleen Restifo, Ph.D.; Dolores Malaspina, M.D.; Charles A. Kaufmann, M.D.; Xavier F. Amador, Ph.D.; Scott A. Yale, M.S.W.; Jack M. Gorman, M.D.
Tetrabenazine Treatment for Tardive Dyskinesia: Assessment by Randomized Videotape Protocol
William G. Ondo, M.D.; Philip A. Hanna, M.D.; Joseph Jankovic, M.D.
Risperidone-Induced Tardive Dyskinesia
KYUNG SUE HONG, M.D.; SEONG SIM CHEONG, M.D.; JONG-MIN WOO, M.D.; EYONG KIM, M.D.
Dr. Bä:ckman and Colleagues Reply
LARS BÄCKMAN, PH,D.; BRENT J. SMALL, PH.D.; YVONNE FORSELL, M.D., PH.D.; BENGT WINBLAD, M.D., PH.D.; ANNA-KARIN BERGER, M.SC.
Dr. Ursano and Colleagues Reply
ROBERT J. URSANO, M.D.; RICHARD S. EPSTEIN, M.D.; CAROL S. FULLERTON, PH.D.
The “Very Old”
OLIVER FRENCH, M.D.
Skills Training or Occupational Therapy for Persistent Schizophrenia
FRANKLIN STEIN, PH.D., O.T.R./L., F.A.O.T.A.
Skills Training or Occupational Therapy for Persistent Schizophrenia
JANET FALK-KESSLER, ED.D., O.T.R., F.A.O.T.A.
Dr. Liberman Replies
ROBERT PAUL LIBERMAN, M.D.
Skills Training or Occupational Therapy for Persistent Schizophrenia
MARGARET DRAKE, PH.D., O.T.R./L., A.T.R.-B.C., F.A.O.T.A.; CAROL TUBBS, M.A., O.T.R./L.; JOYCE TITUS, M.H.S., O.T.R./L.; LORRAINE STREET, M.O.T., O.T.R./L.; PETER GIROUX, M.H.S., O.T.R./L.; BETTE GROAT, M.A., O.T.R./L.; DONA LEE ANDREWS, A.B.D., M.SC., O.T.R./L.; ROBIN DAVIS, M.S., O.T.R./L.; ROSEMARY TENNANT, O.T.R./L.; AMELIA BARBARA EDWARDS, O.T.R./L.; PATSY HESTER, MED. O.T.